The efficacy and safety of mizoribine in living donor kidney transplantation: a 24-week, open-label, prospective study (phase III clinical trial)

Author: Cho D.K.   Kim J.H.   Park S.H.   Kim J.C.   Kim C.D.   Baek M.Y.   Kim S.J.   Kim S.H.   Kwon T.H.   Kim Y.L.   Kim Y.W.   Chang S.K.  

Publisher: Elsevier

ISSN: 0041-1345

Source: Transplantation Proceedings, Vol.33, Iss.7, 2001-11, pp. : 3256-3258

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content